Mitesco Inc
OTC:MITI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.06
0.77
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
M
|
Mitesco Inc
OTC:MITI
|
905.4k USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
94.2B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
72.5B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
60.5B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.3B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.4B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20.3B USD |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.6B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR |
Loading...
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
11B AUD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Mitesco Inc
Glance View
Mitesco, Inc. engages in the development, production, and sale of pharmaceuticals. The company is headquartered in Saint Louis Park, Minnesota and currently employs 24 full-time employees. The company went IPO on 2011-11-03. The firm is focused on acquisition of compounding pharmacy companies. The company is also focused on developing a portfolio of companies that provide healthcare technology solutions. Its operations are based on establishing medical clinics utilizing nurse practitioners under The Good Clinic name and development and acquisition of telemedicine technology. The company has opened its first The Good Clinic in Minneapolis, Minnesota.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Mitesco Inc is -2 133.6%, which is above its 3-year median of -3 897.9%.
Over the last 3 years, Mitesco Inc’s Operating Margin has increased from -3 687% to -2 133.6%. During this period, it reached a low of -14 958.3% on Jun 30, 2024 and a high of -1 534.8% on Dec 31, 2022.